243 related articles for article (PubMed ID: 32395200)
1. Periocular basal cell carcinoma - clinical perspectives.
Furdova A; Kapitanova K; Kollarova A; Sekac J
Oncol Rev; 2020 Feb; 14(1):420. PubMed ID: 32395200
[TBL] [Abstract][Full Text] [Related]
2. Ocular basal cell carcinoma: a brief literature review of clinical diagnosis and treatment.
Shi Y; Jia R; Fan X
Onco Targets Ther; 2017; 10():2483-2489. PubMed ID: 28507440
[TBL] [Abstract][Full Text] [Related]
3. Vismodegib as an adjuvant treatment for periorbital basal cell carcinoma: a case report and review of literature.
Jabbehdari S; Veluvolu M; Kornhauser T; Jennings TA; Pemberton JD
Ann Transl Med; 2024 Jun; 12(3):54. PubMed ID: 38911557
[TBL] [Abstract][Full Text] [Related]
4. Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell Carcinoma.
Sagiv O; Ding S; Ferrarotto R; Glisson B; Altan M; Johnson F; Elamin Y; Thakar SD; Nagarajan P; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2019; 35(4):350-353. PubMed ID: 30365473
[TBL] [Abstract][Full Text] [Related]
5. Vismodegib and orbital excision for treating locally advanced basal cell carcinoma.
Hogarty DT; Dewhurst NG; Burt B
Int Med Case Rep J; 2018; 11():177-179. PubMed ID: 30104907
[TBL] [Abstract][Full Text] [Related]
6. Vismodegib for periocular and orbital basal cell carcinoma.
Gill HS; Moscato EE; Chang AL; Soon S; Silkiss RZ
JAMA Ophthalmol; 2013 Dec; 131(12):1591-4. PubMed ID: 24136169
[TBL] [Abstract][Full Text] [Related]
7. Advanced Periocular Basal Cell Carcinoma with Orbital Invasion: Update on Management and Treatment Advances.
Bengoa-González A; Mencía-Gutiérrez E; Garrido M; Salvador E; Lago-Llinás MD
J Ophthalmol; 2024; 2024():4347707. PubMed ID: 38456099
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant Vismodegib and Mohs Micrographic Surgery for Locally Advanced Periocular Basal Cell Carcinoma.
González AR; Etchichury D; Gil ME; Del Aguila R
Ophthalmic Plast Reconstr Surg; 2019; 35(1):56-61. PubMed ID: 30444747
[TBL] [Abstract][Full Text] [Related]
9. RECURRENT PERIOCULAR BASAL CELL CARCINOMA. CASE REPORT.
Prídavková Z; Bieliková A; Ferková N; Lysková D
Cesk Slov Oftalmol; 2021; 77(4):208-213. PubMed ID: 34507497
[TBL] [Abstract][Full Text] [Related]
10. [Advanced periocular basal cell carcinoma-a therapeutic challenge].
Lauterbach B; Kakkassery V; Debus D; Heindl LM; Schultz ES
Ophthalmologe; 2019 Mar; 116(3):273-277. PubMed ID: 29777299
[TBL] [Abstract][Full Text] [Related]
11. Vismodegib for Locally Advanced Periocular and Orbital Basal Cell Carcinoma: A Review of 15 Consecutive Cases.
Wong KY; Fife K; Lear JT; Price RD; Durrani AJ
Plast Reconstr Surg Glob Open; 2017 Jul; 5(7):e1424. PubMed ID: 28831360
[TBL] [Abstract][Full Text] [Related]
12. Management of periorbital basal cell carcinoma with orbital invasion.
Sun MT; Wu A; Figueira E; Huilgol S; Selva D
Future Oncol; 2015 Nov; 11(22):3003-10. PubMed ID: 26437207
[TBL] [Abstract][Full Text] [Related]
13. Periocular Basal Cell Carcinoma Predictors for Recurrence and Infiltration of the Orbit.
Furdova A; Lukacko P
J Craniofac Surg; 2017 Jan; 28(1):e84-e87. PubMed ID: 27906855
[TBL] [Abstract][Full Text] [Related]
14. Supraestructure maxillectomy and orbital exenteration for treatment of basal cell carcinoma of inferior eyelid: case report and review.
Sebastián Villalón-López J; Arturo Valle-Mejía C; Patiño-Lara A; Moreno-Pérez Bertha A; Alejo Muñoz-López J; Alcantar-Andrade A
J Cancer Res Ther; 2005; 1(3):132-5. PubMed ID: 17998643
[TBL] [Abstract][Full Text] [Related]
15. [Vismodegib Therapy for Periocular Basal Cell Carcinoma].
Keserü M; Green S; Dulz S
Klin Monbl Augenheilkd; 2017 Jan; 234(1):64-69. PubMed ID: 28135752
[No Abstract] [Full Text] [Related]
16. Risk factors for orbital exenteration in periocular Basal cell carcinoma.
Iuliano A; Strianese D; Uccello G; Diplomatico A; Tebaldi S; Bonavolontà G
Am J Ophthalmol; 2012 Feb; 153(2):238-241.e1. PubMed ID: 21982108
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Orbital Invasion in Malignant Eyelid Tumors, Is Orbital Exenteration Still Necessary?
Gąsiorowski K; Gontarz M; Marecik T; Szczurowski P; Bargiel J; Zapała J; Wyszyńska-Pawelec G
J Clin Med; 2024 Jan; 13(3):. PubMed ID: 38337420
[TBL] [Abstract][Full Text] [Related]
18. Linear basal cell carcinoma: a distinct clinical entity in the periocular region.
Mavrikakis I; Malhotra R; Barlow R; Huilgol SC; Selva D
Ophthalmology; 2006 Feb; 113(2):338-42. PubMed ID: 16406534
[TBL] [Abstract][Full Text] [Related]
19. Histological subtypes of periocular basal cell carcinoma.
Wu A; Sun MT; Huilgol SC; Madge S; Selva D
Clin Exp Ophthalmol; 2014; 42(7):603-7. PubMed ID: 24533627
[TBL] [Abstract][Full Text] [Related]
20. Emerging trends in the treatment of advanced basal cell carcinoma.
Migden MR; Chang ALS; Dirix L; Stratigos AJ; Lear JT
Cancer Treat Rev; 2018 Mar; 64():1-10. PubMed ID: 29407368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
